Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 17 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-24 Harmon Cyrus Director Sale −12,500 $11.71 $146K 702,770
2026-07-23 Harmon Cyrus Director Sale −12,500 $11.58 $145K 715,270
2026-06-18 Harmon Cyrus Director Grant or award · Stock Option (Right to Buy) +29,500 29,500
2026-01-20 Harmon Cyrus Director Sale −10,000 $26.88 $269K 727,770
2026-01-14 Harmon Cyrus Director Sale −3,489 $29.12 $102K 737,770
2025-12-22 Harmon Cyrus Director Sale −2,881 $28.53 $82K 741,259
2025-09-18 Harmon Cyrus Director Sale −10,000 $8.33 $83K 744,140
2025-09-18 Harmon Cyrus Director Sale −3,086 $8.32 $26K 117,028
2025-09-16 Harmon Cyrus Director Sale −10,000 $8.04 $80K 754,140
2025-09-16 Harmon Cyrus Director Sale −1,914 $8.08 $15K 120,114
2025-06-11 Harmon Cyrus Director Grant or award · Stock Option (right to buy) +24,150 24,150
2024-12-11 Harmon Cyrus Director Sale −7,958 $8.66 $69K 764,319
2024-12-11 Harmon Cyrus Director Sale −179 $9.39 $2K 764,140
2024-12-10 Harmon Cyrus Director Sale −8,256 $9.37 $77K 772,277
2024-12-09 Harmon Cyrus Director Grant or award +29,250 780,533
2024-07-30 Harmon Cyrus Director Sale 10b5-1 −934 $15.55 $15K 751,283
2024-07-29 Harmon Cyrus Director Sale 10b5-1 −4,066 $15.58 $63K 752,217
2024-07-11 Harmon Cyrus Director Sale 10b5-1 −5,000 $12.26 $61K 756,283
2024-06-28 Harmon Cyrus Director Sale 10b5-1 −20,000 $10.77 $215K 761,283
2024-06-14 Harmon Cyrus Director Grant or award · Stock Option (Right to Buy) +23,000 23,000

Page 1 of 4 · 62 trades